CN102950025B - Asymmetric hydrogenation catalyst of imine and its use - Google Patents

Asymmetric hydrogenation catalyst of imine and its use Download PDF

Info

Publication number
CN102950025B
CN102950025B CN201110242308.3A CN201110242308A CN102950025B CN 102950025 B CN102950025 B CN 102950025B CN 201110242308 A CN201110242308 A CN 201110242308A CN 102950025 B CN102950025 B CN 102950025B
Authority
CN
China
Prior art keywords
imine
alkyl
catalyst
formula
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110242308.3A
Other languages
Chinese (zh)
Other versions
CN102950025A (en
Inventor
姜鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Zhonghua Technology Co ltd
Original Assignee
Shenyang Research Institute of Chemical Industry Co Ltd
Sinochem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Research Institute of Chemical Industry Co Ltd, Sinochem Corp filed Critical Shenyang Research Institute of Chemical Industry Co Ltd
Priority to CN201110242308.3A priority Critical patent/CN102950025B/en
Publication of CN102950025A publication Critical patent/CN102950025A/en
Application granted granted Critical
Publication of CN102950025B publication Critical patent/CN102950025B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses an asymmetric hydrogenation catalyst of imine. The asymmetric hydrogenation catalyst of imine is an in-situ mixture of a chiral ligand having a structure represented by formula I and a metallic iridium complex, or a complex generated from the chiral ligand of the formula I and the metallic iridium complex, wherein R1 in the formula I is a C1-C5 alkyl group, R2, R3 and R4 in the formula I can be same or different from each other, and are respectively selected from C1-C6 straight-chain or branched-chain alkyl groups, and aryl groups substituted by zero-three C-C6 alkyl groups, and n in the formula I is 1-6; and the metallic iridium complex is chloro-1,5-cyclooctadiene iridium(I) dimer. The asymmetric hydrogenation catalyst of imine has the advantages of easy large-scale preparation of the ligand, simple operation, and realization of continuous operation, is suitable for the large-scale preparation of chiral amine, and is especially suitable for preparing the chiral intermediate of a pesticide S-metolachlor.

Description

Asymmetric hydrogenation catalyst for imine and application thereof
Technical Field
The invention belongs to the field of organic synthesis, relates to a bifunctional asymmetric catalyst with a novel structure and application of the catalyst in preparation of a chiral amine pesticide intermediate by imine asymmetric catalytic hydrogenation, and particularly relates to an imine asymmetric hydrogenation catalyst and application thereof.
Technical Field
Asymmetric hydrogenation of prochiral imines is one of the important methods for the synthesis of chiral amines, and many catalysts have been selected (Tang W and Zhang X, chem. rev., 2003, 103, 3029.). The selection and use of asymmetric catalysts are key to the success of the reaction, and at present, the catalysts either only have good enantioselectivity of products and low chemical activity, so that the practical utilization value is lost; or the catalyst has good chemical activity and low enantioselectivity, so that the use value is lost. Asymmetric hydrogenation is particularly difficult to achieve with good enantioselectivity of the product, since the open-chain imine is a mixture of cis and trans geometric isomers during synthesis, but the situation has changed in recent years. Patent (EP0691949B1) discloses the use of { (R) -1- [ (S) -2-diphenylphosphinomethane-based ] } ethyl-bis- (3, 5-dimethyl-phenyl) phosphine as ligand to form a catalyst precursor in situ with an iridium complex, in the presence of an acid and tetrabutylammonium iodide at 50 ℃ and 80 atm hydrogen, to catalyze the asymmetric hydrogenation of linear imines, which is reacted in an autoclave to give chiral amine intermediates up to 76% e.e (enantiomeric excess), meeting the requirements as intermediates for pesticides. However, the existing catalysts require the use of a large amount of quaternary ammonium iodide, which makes the post-treatment cumbersome and increases the cost.
Disclosure of Invention
The invention aims to provide a bifunctional asymmetric catalyst with a novel structure for asymmetric catalytic hydrogenation of imine, which meets the requirement of synthesizing a chiral intermediate of a pesticide by large-scale asymmetric catalytic hydrogenation, and particularly meets the requirement of preparing the chiral intermediate of a pesticide of Gordon.
The technical scheme of the invention is as follows:
an imine asymmetric hydrogenation catalyst is an in-situ mixture or a newly generated complex of a ferrocene-derived quaternary ammonium iodide salt chiral ligand with a diphosphine ligand and a metal iridium complex shown in a formula I:
in the formula: r1Is C1-C5An alkyl group; r2、R3、R4Can be the same or different and are respectively selected from C1-C6Straight or branched chain alkyl, 0-3C1-C6Alkyl-substituted aryl; n is 1-6;
the metal iridium complex is dimeric 1, 5-cyclooctadiene iridium chloride (cyclooctadiene abbreviated as DOC), and is commercially available or prepared according to a known method.
Preferred catalysts of the invention are: in the formula: r1Is C1-C3An alkyl group; r2、R3、R4Can be the same or different and are respectively selected from C1-C4Straight or branched chain alkyl, 0-2C1-C6Alkyl-substituted aryl; n is 1-4;
the preparation method of the catalyst comprises the following steps:
the preparation method of the catalyst is specifically exemplified by:
the method comprises the steps of taking diphosphine compounds such as { (R) -1- [ (S) -2-di-phenyl-phosphino-cyclopentadienyl iron group ] } -ethyl-di- (3, 5-dimethyl-phenyl) phosphine and the like as raw materials, reacting with 2.5 times of hydroborane to prepare a diphosphine-hydroborane compound, reacting with butyl lithium-tetramethyl ethylenediamine as a lithiating agent in situ to obtain a derivative aldehyde compound, reducing the compound in methanol by taking sodium borohydride as a reducing agent to obtain an alcohol compound, converting the alcohol into an iodide in situ, reacting the generated iodide with tributylamine to obtain a new diphosphine compound compounded with the hydroborane, and dissociating a ligand from the diethylamine before using the compound. The other ligands of formula I of the invention can be prepared by changing the raw materials in the same way.
The ligand reacts with dimeric 1, 5-cyclooctadiene iridium chloride and is used for preparing a complex in situ, the complex is directly used as a good asymmetric hydrogenation catalyst in asymmetric hydrogenation reaction, and the good practicability is achieved; the quaternary ammonium iodide salt does not need to be added under certain catalyst concentration. The dosage of the catalyst suitable for the method is 0.0002-0.3 mol% of the raw material imine; further preferably, the amount of the catalyst is 0.0005 to 0.1 mol% based on the starting imine. The catalyst of the invention is used for catalyzing asymmetric hydrogenation reaction of imine, the obtained chiral amine reaches more than 70% e.e and can reach more than 77% e.e, and the requirement of preparing chiral amine products, such as chiral intermediates for synthesizing pesticide Tunduer, is completely met. The inventor uses a new ligand to modify the catalyst structure, and adds a quaternary ammonium iodide salt group on a derivative ligand, namely, the catalyst can partially play a role in phase transfer of the added quaternary ammonium salt, so that the use amount of the quaternary ammonium iodide salt can be removed or reduced, a good catalytic effect is obtained, the production cost is reduced, and the post-treatment procedure is simplified.
The catalyst of the invention is suitable for preparing chiral amine intermediates by asymmetric catalytic hydrogenation as shown in the following:
in the formula: r5Is selected from C1-C6Alkyl, phenyl, naphthyl or heteroaryl; r6、R7Can be the same or different and are respectively selected from C1-C3Alkyl, phenyl or naphthyl, said group may further contain C1-C3Alkyl or phenyl.
The amines used in the in situ synthesis of the imines according to the invention are selected from C1-C6Aliphatic, aniline, naphthylamine or heterocyclic aromatic amines of (a); the ketone for synthesizing imine is selected from symmetric or asymmetric aliphatic ketone or aryl substituted aliphatic ketone, or symmetric or asymmetric aromatic ketone and symmetric or asymmetric aromatic ketone with substituent; the amine and ketone are dehydrated and condensed, and imine obtained by in situ or separation is asymmetrically hydrogenated to synthesize chiral amine under the catalysis of the catalyst under the condition of solvent or no solvent. The reaction conditions are within the skill of the art. In practice, at low reactant/catalyst (s/c, mol/mol) (e.g., s/c less than 14 ten thousand) no iodide or organic iodide salt is required; when the s/c value is high, the reaction is facilitated by adding an iodide salt. When an iodide salt is used, the iodide salt used is an inorganic iodide salt or an organic iodide salt, preferably an organic iodide salt such as benzyltrimethylammonium iodide or tetrabutylammonium iodide. The amount of the iodine salt to be used is in the range of 0.001 to 5.0 mol%, preferably 0.001 to 1.0 mol%, based on the raw material imine. When a solvent is used, an acid (organic acid or inorganic acid) is usually used as the solvent, and an organic acid, particularly acetic acid, is preferred. The amount of solvent used is 1.0-50%, especially 5.0-50%, based on the weight of the starting imine.
The catalyst provided by the invention is preferably used for preparing 2-methyl-6-ethyl-aniline by asymmetric catalytic hydrogenation of imine generated by 2-methyl-6-ethyl-aniline and methoxy acetone:
specific procedures of the present invention are listed below (wherein the ferrocene-derived quaternary ammonium iodonium salt chiral ligand with bisphosphine ligand of formula I is prepared as described above):
1. in an autoclave with a proper volume, under the protection of nitrogen, a catalytic amount of dimeric iridium 1, 5-cyclooctadiene chloride complex and a quaternary ammonium iodide salt chiral ligand of diphosphine ligands such as { (R) -1- [ (S) -2-di-phenyl-phosphino-cyclopentadienyl iron base ] } -ethyl-di- (3, 5-dimethyl-phenyl) phosphine are mixed in organic acid, preferably acetic acid, the amount of the acetic acid is up to 50 percent of the total material weight, for the reaction with a high S/c value, a proper amount of tetrabutyl ammonium iodide needs to be added, and the prepared mixture is used as a catalyst under the protection of nitrogen.
2. Under the protection of nitrogen, imine generated by 2-methyl-6-ethyl-aniline and methoxy acetone is added into the autoclave. Replacing nitrogen with hydrogen, fixing the reaction solution under certain pressure and reacting at room temperature or 50 ℃ until the system can not absorb hydrogen any more. Discharging the residual air, transferring the material into a reduced pressure distillation device, recovering acetic acid and evaporating out a hydrogenation product; the content was analyzed by gas chromatography and the product e.e value (enantiomeric excess) was analyzed by liquid phase (with chiral column).
Experiments show that the catalyst of the invention is used, the imine/catalyst ratio is 100-500000, under 10-100 atmospheric pressure hydrogen, in acetic acid and in the presence or absence of tetrabutyl ammonium iodide, the product is completely converted within 24 hours, and the e.e value of the product is up to more than 77%. Increasing the reaction temperature increases the reaction rate, but the e.e value of the product decreases slightly.
The ligand is easy to obtain, and the preparation method is convenient for mass production; the method is simple and convenient to operate, can realize continuous operation, is suitable for large-scale preparation of chiral amine, has the e.e value of the product higher than the best level (more than 1 percent) in the prior art, and completely meets the requirement of being used as a pesticide intermediate. In the reaction process, the organic iodide derived from the chiral ligand can undoubtedly enable the ligand to play a role in chiral induction, and simultaneously play a role in phase transfer to improve the efficiency of the catalyst; moreover, as the ligand is quaternary ammonium salt and has positive charge, the catalyst can be separated and recovered through a medium or macromolecular anion resin after catalytic reaction, and the operation is simple and easy.
Detailed Description
The examples described below serve to illustrate the invention in further detail. In these examples, unless otherwise specified, the order of addition of the reaction mass can be combined as desired between the masses, the imine used being obtained by dehydro-condensation of 2-methyl-6-ethyl-aniline with methoxyacetone and measured in g (mol), the catalyst being exemplified by a mixture of dimeric 1, 5-cyclooctadieneiridium chloride and { (R) -1- [ (S) -2-di-phenyl-phosphino-1' -methylene-tri-butyl ammoniuodide-cyclopentadienyl ] } -ethyl-bis- (3, 5-dimethyl-phenyl) phosphine (ligand for short), all in mg (mg) (mmol), the acid used being exemplified by acetic acid and measured in mL (mL), tetrabutylammonium iodide being measured in mg (mg) (mmol), the content of hydrogenation products is detected by high performance liquid chromatography analysis, and the conditions are as follows: a chromatographic column: eclipse XDB-C18150 mm X4.6 mm (i.d.), 5-Micron stainless steel column; column temperature: 30 ℃; mobile phase: acetonitrile to water 70: 30 (V/V); flow rate: 0.6 ml/min; detection wavelength: 254 nm; sample introduction amount: 20 mu l of the mixture; or by GC under the following analytical conditions: using Hp-5 gas chromatographic column, initially heating to 60 deg.C (hold 3min), heating to 160 deg.C at 20 deg.C/min, and heating to 220 deg.C (hold 30min) at 5 deg.C/min; e.e values were done by HPLC (Agilent 1200) under the analysis conditions: using an AD-H chiral liquid phase column, wherein the flow rate of a mobile phase n-hexane to isopropanol is 95: 5: v is 1.0 and the detection wavelength λ is 220 nm. E.e value of the hydrogenation product is detected by high performance liquid chromatography analysis, and conditions are as follows: a chromatographic column: CHIRALPAK OD-H250 mm by 4.6mm (i.d.) stainless steel column; column temperature: 30 ℃; mobile phase: n-hexane to isopropanol 99.8 to 0.2 (V/V); flow rate: 0.8 ml/min; detection wavelength: 254 nm; sample introduction amount: 1 mul; s/c is the starting imine/catalyst (mol/mol).
Example 1
Under the protection of nitrogen, ligand 14mg, [ Ir (COD) Cl]25mg and 10mL of acetic acid were charged into a 100mL autoclave, and 44.9g of imine (s/c: 3.0 ten thousand) was added thereto, followed by installation of the autoclave and replacement with 10 atmospheres of hydrogen three times (the same procedure in each example below); introducing 80-atmosphere hydrogen, heating to 50 ℃ under stirring, stopping the reaction after 5 hours, analyzing the conversion rate of the raw materials by using a gas chromatography to be 100%, and distilling under reduced pressure to obtain 41.5g of a product with the yield of 91.5%, and analyzing by using a high performance liquid chromatography to obtain the product with the e.e value of 74.6%.
Example 2
The reaction was stopped by reacting the mixture at room temperature for 24 hours under the same conditions as in example 1, and the conversion of the raw material was 97.6% by gas chromatography, and the product was distilled under reduced pressure to give 41.0g, yield 90.4% by high performance liquid chromatography, and e.e. value was 76.0%.
Example 3
Otherwise, the reaction was stopped after 24 hours by introducing 50 atmospheres of hydrogen gas, and the conversion of the starting material was analyzed by gas chromatography and the e.e value was 73.6% by high performance liquid chromatography as in example 2.
Example 4
Under the protection of nitrogen, ligand 2.6mg, [ Ir (COD) Cl]21mg、Bu4NI 15mg and 10mL of acetic acid were charged in a 100mL autoclave, and after 44.5g of imine (s/c: 14.8 ten thousand) was added, the autoclave was placed, and the reaction was stopped after introducing 80 atm hydrogen gas and reacting at room temperature for 36 hours with stirring, and the conversion of the raw material was 100% by gas chromatography and the e.e value was 73.6%.
Example 5
Under the protection of nitrogen gas, ligand 2.6mg, [ Ir (COD) Cl]21mg and 10mL of acetic acid were charged in a 100mL autoclave, 44.5g of imine (s/c: 14.8 ten thousand) was added, the autoclave was placed, and the reaction was stopped after introducing 80 atm hydrogen gas and reacting at room temperature for 36 hours with stirring, and the reaction was carried out in a gas phaseThe chromatographic analysis showed 78.5% conversion of the starting material and an e.e value of 73.1%.
Example 6
Ligand 126mg, [ Ir (COD) Cl]250mg and 30mL of acetic acid were placed in a 100mL autoclave, and after addition of 44.5g of imine (s/c 0.30 ten thousand), the autoclave was set up, purged with 10 atmospheres of hydrogen, and so on for 3 times; introducing 80-atmosphere hydrogen, reacting at room temperature for 24 hours under stirring, stopping the reaction, and analyzing by gas chromatography, wherein the conversion rate of the raw materials is 100 percent, and the e.e value is 76.8 percent.
Example 7
Otherwise, the reaction was stopped by introducing 40 atmospheres of hydrogen gas and reacting for 24 hours under the same conditions as in example 6, and the conversion of the raw material was analyzed by gas chromatography to be 100% and the e.e value was 75.9% by high performance liquid chromatography.
Example 8
Otherwise, the reaction was stopped after 24 hours by supplying 100 atm hydrogen gas and the conversion of the raw material was analyzed by gas chromatography to be 100% and the e.e value was 77.4% by high performance liquid chromatography, as in example 6.
Comparative example
Otherwise, the catalyst ligand was changed to equimolar { (R) -1- [ (S) -2-bis-phenyl-phosphinotrieneiron base ] } -ethyl-bis- (3, 5-dimethyl-phenyl) phosphine under the same conditions as in example 4, and the reaction was stopped after 36 hours at room temperature, and the conversion of the raw material was 100% by gas chromatography and the e.e value was 76.1%.

Claims (4)

1. An asymmetric hydrogenation catalyst for imine, which is characterized in that: an in situ mixture or a newly formed complex of a chiral ligand of formula I:
in the formula: r1Is C1-C5An alkyl group; r2、R3、R4Can be the same or different, eachIs selected from C1-C6Straight or branched chain alkyl, 0-3C1-C6Alkyl-substituted aryl; n is 1-6;
the metal iridium complex is dimeric 1, 5-cyclooctadiene iridium chloride.
2. The catalyst of claim 1, wherein: r1Is C1-C3An alkyl group; r2、R3、R4Can be the same or different and are respectively selected from C1-C4Straight or branched chain alkyl, 0-2C1-C6Alkyl-substituted aryl; n is 1-4.
3. Use of a catalyst according to claim 1 or 2 for the preparation of a chiral amine intermediate having the structure:
in the formula: r5Is selected from C1-C6Alkyl, phenyl, naphthyl or heteroaryl; r6、R7Can be the same or different and are respectively selected from C1-C3Alkyl, phenyl or naphthyl; said group may further contain C1-C3Alkyl or phenyl;
or,
r5 is selected from phenyl, further containing an ethyl group at the C2 position and a methyl group at the C6 position on the R5; r6 is selected from methyl; r7 is selected from methyl, and R7 further contains methoxy;
or,
r5 is selected from phenyl, further containing an ethyl group at the C2 position and a methyl group at the C6 position on the R5; r6 is selected from methyl, and R6 further contains methoxy; r7 is selected from methyl.
4. Use according to claim 3, characterized in that: the catalyst is used for preparing the compound shown as the following formula,
CN201110242308.3A 2011-08-23 2011-08-23 Asymmetric hydrogenation catalyst of imine and its use Expired - Fee Related CN102950025B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110242308.3A CN102950025B (en) 2011-08-23 2011-08-23 Asymmetric hydrogenation catalyst of imine and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110242308.3A CN102950025B (en) 2011-08-23 2011-08-23 Asymmetric hydrogenation catalyst of imine and its use

Publications (2)

Publication Number Publication Date
CN102950025A CN102950025A (en) 2013-03-06
CN102950025B true CN102950025B (en) 2014-09-10

Family

ID=47759749

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110242308.3A Expired - Fee Related CN102950025B (en) 2011-08-23 2011-08-23 Asymmetric hydrogenation catalyst of imine and its use

Country Status (1)

Country Link
CN (1) CN102950025B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106810554B (en) * 2017-01-14 2019-02-15 山东罗欣药业集团恒欣药业有限公司 A kind of preparation method of Tadalafei compound
CN110551037B (en) * 2018-05-31 2021-11-09 中国科学院大连化学物理研究所 Method for catalyzing asymmetric hydrogenation of imine by iridium/chiral diphosphine system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646590A1 (en) * 1993-10-01 1995-04-05 Ciba-Geigy Ag Ferrocenyldiphosphines substituted with fluoroalkyl groups as ligands for homogeneous catalysis
US5466844A (en) * 1993-02-26 1995-11-14 Ciba-Geigy Corporation Ferrocene diphosphines as ligands for homogeneous catalysts
CN1139930A (en) * 1994-02-02 1997-01-08 希巴-盖吉股份公司 Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
EP0691949B1 (en) * 1994-02-02 1998-10-14 Novartis AG Process for the hydrogenation of imines
CN101857612A (en) * 2010-06-11 2010-10-13 南京工业大学 Chiral diphosphine ligand, iridium composite catalyst thereof, preparation method and application of chiral diphosphine ligand in asymmetric hydrogenation synthesis of -metolachlor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466844A (en) * 1993-02-26 1995-11-14 Ciba-Geigy Corporation Ferrocene diphosphines as ligands for homogeneous catalysts
EP0646590A1 (en) * 1993-10-01 1995-04-05 Ciba-Geigy Ag Ferrocenyldiphosphines substituted with fluoroalkyl groups as ligands for homogeneous catalysis
CN1139930A (en) * 1994-02-02 1997-01-08 希巴-盖吉股份公司 Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
EP0691949B1 (en) * 1994-02-02 1998-10-14 Novartis AG Process for the hydrogenation of imines
CN101857612A (en) * 2010-06-11 2010-10-13 南京工业大学 Chiral diphosphine ligand, iridium composite catalyst thereof, preparation method and application of chiral diphosphine ligand in asymmetric hydrogenation synthesis of -metolachlor

Also Published As

Publication number Publication date
CN102950025A (en) 2013-03-06

Similar Documents

Publication Publication Date Title
Wu et al. Synergistic Pd/Cu catalysis in organic synthesis
Shirakawa et al. Kinetic Resolution of Axially Chiral 2-Amino-1, 1′-Biaryls by Phase-Transfer-Catalyzed N-Allylation.
Hu et al. ZnCl2‐promoted asymmetric hydrogenation of β‐secondary‐amino ketones catalyzed by a P‐chiral Rh–bisphosphine complex
Jin et al. Highly Active, Well‐Defined (Cyclopentadiene)(N‐heterocyclic carbene) palladium Chloride Complexes for Room‐Temperature Suzuki–Miyaura and Buchwald–Hartwig Cross‐Coupling Reactions of Aryl Chlorides and Deboronation Homocoupling of Arylboronic Acids
CN104710406B (en) A kind of method of the outer amine of 3 amine asymmetric hydrogenation synthesis of chiral ring of iridium catalysis quinoline
CN102951980A (en) Asymmetric catalytic hydrogenation method of imine
Lu et al. Highly enantioselective catalytic alkynylation of ketones–A convenient approach to optically active propargylic alcohols
CN109651115B (en) Method for preparing L-menthone
AU2009262693B2 (en) Synthesis of chiral amines
CN102950025B (en) Asymmetric hydrogenation catalyst of imine and its use
Lv et al. A practical Ti-salen catalyst based on dimeric salen ligand for asymmetric addition of trimethylsilyl cyanide to aldehydes
CN105593220A (en) Process for the production of furanic compounds comprising at least one amine function
Maj et al. Asymmetric hydrogenation of 2, 3-dihydro-1H-inden-1-one oxime and derivatives
CN106892826B (en) A kind of preparation method and application of amine and imines N-methyl
CN102950024B (en) Catalyst for asymmetric catalytic hydrogenation of imine
CN111116450B (en) Axial chiral naphthylamine squaramide organic catalyst, and preparation method and application thereof
CN109651160A (en) A method of catalysis phenylacetylene hydroamination reaction prepares olefinic amine compound
CN109651159A (en) A kind of method that hydrogen migration selective reduction nitrile prepares primary amine
CN109422602A (en) A kind of method of asymmetric hydrogenation imines preparation Chiral Amine
CN110372514B (en) Method for catalyzing asymmetric Michael addition reaction and catalyst thereof
CN113354500B (en) Method for preparing 1,5-diene derivative
CN111825508B (en) Preparation method of dihydro 9-phenanthrene amine compound and chiral product prepared by same
CN101797519B (en) Application of fluoro-diphenyl sulfimide as nitrogen heterocyclic Diels-Alder reaction catalyst
CN109574867B (en) Method for synthesizing chiral tertiary amine by asymmetric hydrogenation of ruthenium-catalyzed arylamine compound
CN109912467A (en) A kind of synthetic method of 2- aryl phenylethylamine derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160119

Address after: 110021 Liaodong Road, Tiexi District, Liaoning, No. 8-1, No.

Patentee after: SHENYANG SINOCHEM AGROCHEMICALS R&D Co.,Ltd.

Address before: 100031 Beijing, Xicheng District, the door of the revitalization of the main street, No. 28

Patentee before: SINOCHEM Corp.

Patentee before: SHENYANG RESEARCH INSTITUTE OF CHEMICAL INDUSTRY Co.,Ltd.

TR01 Transfer of patent right

Effective date of registration: 20180619

Address after: 200120 China (Shanghai) free trade pilot area No. 581 Shen Kuo Road

Patentee after: SHANGHAI ZHONGHUA TECHNOLOGY Co.,Ltd.

Address before: 110021 Shenyang Liaodong Road, Tiexi District, Shenyang, Liaoning 8-1

Patentee before: SHENYANG SINOCHEM AGROCHEMICALS R&D Co.,Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140910

CF01 Termination of patent right due to non-payment of annual fee